IMEC creates spin-off

IMEC, the independent Leuven-based research centre, has announced the creation of a spin-off company named Vivactiss. The company will be active in the discovery process of new drugs, by servicing innovative proprietary microcalorimetry technology in compound profiling and tough target screening. Vivactiss aims at revolutionising both of these under-served and rapidly growing markets by offering an increase in assayable targets at a competitive cost. IMEC’s own incubation fund is providing the company with EUR 600,000 starting capital and it expects 30 staff to be employed at the unit by 2003.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Benelux